Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001558370-25-008914
Filing Date
2025-06-26
Accepted
2025-06-26 16:01:19
Documents
6
Effectiveness Date
2025-06-26

Document Format Files

Seq Description Document Type Size
1 S-8 dwtx-20250626xs8.htm S-8 102937
2 EX-5.1 dwtx-20250626xex5d1.htm EX-5.1 20019
3 EX-23.1 dwtx-20250626xex23d1.htm EX-23.1 2730
4 EX-FILING FEES dwtx-20250626xexfees.htm EX-FILING FEES 12453
5 GRAPHIC dwtx-20250626xex5d1001.jpg GRAPHIC 4128
6 GRAPHIC dwtx-20250626xex5d1002.jpg GRAPHIC 6226
  Complete submission text file 0001558370-25-008914.txt   153934
Mailing Address 44 MILTON AVENUE ALPHARETTA GA 30009
Business Address 44 MILTON AVENUE ALPHARETTA GA 30009 8666208655
Dogwood Therapeutics, Inc. (Filer) CIK: 0001818844 (see all company filings)

EIN.: 854314201 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-288344 | Film No.: 251080294
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)